These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10096532)

  • 1. CD2 and CD3 receptor-mediated tolerance: constraints on T cell activation.
    Punch JD; Lin J; Bluestone J; Bromberg JS
    Transplantation; 1999 Mar; 67(5):741-8. PubMed ID: 10096532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3 and CD2 ligation alters CD49d epitope expression.
    Lin J; Qin L; Chavin KD; Ding Y; Punch JD; Yang Q; Burkly LC; Bromberg JS
    Pathobiology; 1995; 63(3):119-32. PubMed ID: 8821628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3.
    Lin J; Chavin KD; Qin L; Ding Y; Bromberg JS
    Cell Immunol; 1996 Feb; 167(2):249-58. PubMed ID: 8603434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor-independent CD2 signal transduction in FcR+ cells.
    Arulanandam AR; Koyasu S; Reinherz EL
    J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of gamma/delta + T cell clones by single anti-CD2 antibodies.
    Wesselborg S; Janssen O; Pechhold K; Kabelitz D
    J Exp Med; 1991 Feb; 173(2):297-304. PubMed ID: 1703204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2 is a dominant target for allogeneic responses.
    Bai Y; Fu S; Honig S; Wang Y; Qin L; Chen D; Bromberg JS
    Am J Transplant; 2002 Aug; 2(7):618-26. PubMed ID: 12201362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
    Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
    Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the association between PSTPIP and CD2 in murine T cells.
    Bai Y; Ding Y; Spencer S; Lasky LA; Bromberg JS
    Exp Mol Pathol; 2001 Oct; 71(2):115-24. PubMed ID: 11599917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
    J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells.
    Kawaguchi M; Eckels DD
    Hum Immunol; 1995 Jun; 43(2):136-48. PubMed ID: 7591873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
    Musgrave BL; Watson CL; Hoskin DW
    J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor-triggered activation of intraepithelial lymphocytes in vitro.
    Gramzinski RA; Adams E; Gross JA; Goodman TG; Allison JP; Lefrançois L
    Int Immunol; 1993 Feb; 5(2):145-53. PubMed ID: 8383994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.